Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects and Adults With Cystic Fibrosis.
Clinical trial NCT05712538 · COMPLETED
Trial details
- NCT number
- NCT05712538
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2024-07-29
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.